Search

everythinglearnresearchcommunity

for

Search:↓

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Pea sprout extract is safe and effectively reduces hair loss.

TNF-alpha inhibitors can cause various immune-related skin issues.

Leflunomide is more likely to help treat alopecia areata than cause it.

Propylthiouracil can cause hair loss, reduced sweating, and nail issues, but stopping the drug can reverse hair and nail problems.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

A genetic change in the EDAR gene causes the unique hair traits found in East Asians.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

Boys with less severe EDA mutations in XLHED have milder symptoms and better sweat and hair production.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Regulatory T cells are essential for normal and improved wound healing in mice.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.